Loss-of-function mutations in human β-MSH are associated with obesity, despite the presence of functional α-MSH [12–15], suggesting that the overall dose of α- and β-MSH is critical for MC4R activation in the paraventricular nucleus. The gene discussed is STAMBP; the disease is obesity disorder.